Direct and indirect markers of cartilage metabolism in synovial fluid obtained from dogs with hip dysplasia and correlation with clinical and radiographic variables

American Journal of Veterinary Research

Volumn 66, Issue 12, 2005, Pages 2028-2033

  Fujita, Yukihiro ^a   Hara, Yasushi ^a   Nezu, Yoshinori ^a   Yamaguchi, Shinya ^a   Schulz, Kurt S ^b   Tagawa, Masahiro ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN POLYSULFATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANIMAL MODEL; ARTICLE; ARTICULAR CARTILAGE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DOG DISEASE; ENZYME ACTIVITY; FEMALE; GROUPS BY AGE; HIP DYSPLASIA; HIP OSTEOARTHRITIS; JOINT LAXITY; MALE; MEDICAL RECORD; NONHUMAN; PROTEIN CONTENT; PROTEIN METABOLISM; RADIODIAGNOSIS; RANK SUM TEST; SCORING SYSTEM; SYNOVIAL FLUID;

AGE FACTORS; ANIMALS; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CARTILAGE; CELL LINE, TUMOR; DOGS; GLYCOSAMINOGLYCANS; HIP DYSPLASIA, CANINE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 3; MICE; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; CANIS FAMILIARIS;

EID: 33645238062     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.2028     Document Type: Article

References (44)

1. Todhunter RJ, Lust G. Hip dysplasia. Pathogenesis. In: Slatter D, ed. Textbook of small animal surgery. 3rd ed. Philadelphia: WB Saunders Co, 2003;2009-2019.
2. Piermattei DL, Flo GL. The hip joint. In: Piermattei DL, Flo GL, eds. Brinker Piermattei, and Flo's handbook of small animal orthopedics and fracture repair. 3rd ed. Philadelphia: WB Saunders Co, 1997;422-468.
3. Johnston SA. Osteoarthritis. Joint anatomy, physiology, and pathology. Vet Clin North Am Small Anim Pract 1997;27:699-724.
4. Todhunter RJ, Johnston SA. Osteoarthritis. In: Slatter D, ed. Textbook of small animal surgery. 3rd ed. Philadelphia: WB Saunders Co, 2003;2208-2245.
5. Punzi L, Oliviero F, Ramonda R, et al. Laboratory investigations in osteoarthritis. Aging Clin Exp Res 2003;15:373-379.
6. Chu Q, Lopes M, Hayashi K, et al. Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage 2002;10:662-669.
7. Israel HA, Saed-Nejad F, Ratcliffe A. Early diagnosis of osteoarthritis of the temporomandibular joint: correlation between arthroscopic diagnosis and keratan sulfate levels in the synovial fluid. J Oral Maxillofac Surg 1991;49:708-711.
8. Thonar E, Lenz ME, Masuda K, et al. Body fluid markers of cartilage metabolism. In: Seibel MJ, Robins SP, Bilizikian JP, eds. Dynamics of bone and cartilage metabolism. San Diego: Academic Press Inc, 1999;454-455.
9. Lohmander LS, Dahleberg L, Ryd L, et al. Increased levels of proteoglycan fragments in knee joint fluid after joint injury. Arthritis Rheum 1989;32:1434-1442.
10. Innes JF, Sharif M, Barr ARS, et al. Changes in concentrations of biochemical markers of osteoarthritis following surgical repair of ruptured cranial cruciate ligaments in dogs. Am J Vet Res 1999;60:1164-1168.
11. Johnson KA, Hart RC, Chu Q, et al. Concentrations of chondroitin sulfate epitopes 3B3 and 7D4 in synovial fluid after intra-articular and extracapsular reconstruction of the cranial cruciate ligament in dogs. Am J Vet Res 2001;62:581-587.
12. Hegemann N, Kohn B, Brunnberg L, et al. Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis Cartilage 2002;10:714-721.
13. Hay CW, Chu Q, Budsberg SC, et al. Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture. Am J Vet Res 1997;58:1027-1035.
14. Venn G, Nietfeld J, Duits AF, et al. Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis. Arthritis Rheum 1993; 36:819-826.
15. Hegemann N, Wondimu A, Ullrich K, et al. Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis. Vet Immunol Immunopathol 2003;91:199-204.
16. Dassler CL. Canine hip dysplasia: diagnosis and nonsurgical treatment. In: Slatter D, ed. Textbook of small animal surgery. 3rd ed. Philadelphia: WB Saunders Co, 2003;2019-2059.
17. Impellizeri JA, Tetrick MA, Muir P. Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis. J Am Vet Med Assoc 2000;216:1089-1091.
18. Tomlinson JL, Johnson JC. Quantification of measurement of femoral head coverage and Norberg angle within and among breeds of dogs. Am J Vet Res 2000;61:1492-1500.
19. Nakai S, Mizuno K, Kaneta M, et al. A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line. Biochem Biophys Res Commun 1988;154:1189-1196.
20. Nezu Y, Tagawa M, Sakaue Y, et al. Kinetics of endotoxin concentration and tumor necrosis factor-α, interleukin-1-β, and interleukin-6 activities in the systemic and portal circulation during small intestinal ischemia and reperfusion in dogs. Am J Vet Res 2002;63:1680-1686.
21. Shi F, Kurzman D, MacEwen G. In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs. Cancer Biother 1995;10:317-325.
22. Eskandari MK, Nguyen DT, Kunkel SL, et al. WEHI 164 subclone 12 assay for TNF: sensitivity, specificity and reliability. Immunol Invest 1990;19:69-79.
23. Nagase H, Fields CG, Fields GB. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J Biol Chem 1994;269:20952-20957.
24. Goldberg RL, Kolibas LM. An improved method for determining proteoglycans synthesized by precipitation with 1,9-dimethylmethylene blue. Connect Tissue Res 1990;24:265-275.
25. Thonar E. Manicourt. Noninvasive markers in osteoarthritis. In: Moskowitz RW, Howell DS, Altman RD, et al, eds. Osteoarthritis. Diagnosis and medical/surgical management. 3rd ed. Philadelphia: WB Saunders Co, 2001;293-313.
26. Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991;266:2017-2020.
27. Panula HE, Lohmander LS, Ronkko S, et al. Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs. Acta Orthop Scand 1998;69:152-158.
28. Marijnissen ACA, van Roermund PM, TeKoppele JM, et al. The canine 'groove' model, compared with the ACLT model of osteoarthritis. Osteoarthritis Cartilage 2002;10:145-155.
29. Martel-Pelletier J, Welsch DJ, Pelletier JP. Metalloproteinases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 2001;15:805-829.
30. Innes JF, Sharif M, Barr ARS. Relations between biochemical. markers of osteoarthritis and other disease parameters in a population of dogs with naturally acquired osteoarthritis of the genual joint. Am J Vet Res 1998;59:1530-1536.
31. Carney SL, Billingham MEJ, Caterson B, et al. Changes in proteoglycan turnover in experimental canine osteoarthritic cartilage. Matrix 1992;12:137-147.
32. Little CB, Flannery CR, Hughes CE, et al. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J 1999;344:61-68.
33. Fernades JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002;39:237-246.
34. Spreng D, Sigrist N, Jungi T, et al. Nitric oxide metabolite production in the cranial cruciate ligament, synovial membrane, and articular cartilage of dogs with cranial cruciate ligament rupture. Am J Vet Res 2000;61:530-536.
35. Kirker-Head CA, Chandna VK, Agarwal RK, et al. Concentration of substance P and prostaglandin E2 in synovial fluid of normal and abnormal joints of horses. Am J Vet Res 2000;61:714-718.
36. Nishimura M, Segami N, Kaneyama K, et al. Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 2002;40:68-71.
37. Arnalich F, de Miguel E, Perez-Ayala C, et al. Neuropeptides and interleukin-6 in human joint inflammation relationships between intraarticular substance P and interleukin-6 concentrations. Neurosci Lett 1994;170:251-254.
38. Segami N, Miyamaru M, Nishimura M, et al. Does not effusion on T2 magnetic resonance images reflect synovitis? Part 2. Comparison of concentration levels of proinflammatory cytokines and total protein in synovial fluid of the temporomandibular joint with internal derangements and osteoarthrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94:515-521.
39. Shinoda C, Takaku S. Interleukin-1 beta, interleukin-6, and tissue inhibitor of metalloproteinases-1 in the synovial fluid of the temporomandibular joint with respect to cartilage destruction. Oral Dis 2000;6:383-390.
40. Kealy RD, Olsson SE, Monti KL, et al. Effects of limited food consumption on the incidence of hip dysplasia in growing dogs. J Am Vet Med Assoc 1992;201:857-863.
41. Kealy RD, Lawler DF, Ballam JM, et al. Five-year longitudinal study on limited food consumption and development of osteoarthritis in coxofemoral joints of dogs. J Am Vet Med Assoc 1997;210:222-225.
42. Lust G, Williams AJ, Burton-Wurster N, et al. Joint laxity and its association with hip dysplasia in Labrador Retrievers. Am J Vet Res 1993;54:1990-1999.
43. Douglas SW, Williamson HD. The limb bones and joints. In: Douglas SW, Williamson HD, eds. Veterinary radiological interpretation. Philadelphia: Lea & Febiger, 1970;91-121.
44. Kubota E, Imamura H, Kubota T, et al. Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997;55:20-27.